News
-
-
-
-
-
-
-
-
-
-
PRESS RELEASE
Viromed Medical AG: ViroCAP® med successfully completes regulatory process as a Class IIa medical device – starting signal for market launch at the European Wound Congress 2026
Viromed Medical AG announces ViroCAP® med's successful completion of the regulatory process as a Class IIa medical device, paving the way for market launch at the European Wound Congress 2026. Cold plasma technology for wound treatment